Page last updated: 2024-11-06

thyroxine and Squamous Cell Carcinoma of Head and Neck

thyroxine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"Hypothyroidism is a late side effect after curative radiotherapy in the head and neck region."1.42Thyroid dysfunction after intra-arterial chemotherapy for hypopharyngeal and laryngeal cancer. ( Endo, K; Kondo, S; Masatani, T; Murono, S; Tsuji, A; Wakisaka, N; Yoshizaki, T, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, K1
Masatani, T1
Tsuji, A1
Kondo, S1
Wakisaka, N1
Murono, S1
Yoshizaki, T1

Other Studies

1 other study available for thyroxine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Thyroid dysfunction after intra-arterial chemotherapy for hypopharyngeal and laryngeal cancer.
    Auris, nasus, larynx, 2015, Volume: 42, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Case-Control Studies; Chem

2015